RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis

References

• PellegritiGFrascaFRegalbutoCSquatritoSVigneriRWorldwide increasing incidence of thyroid cancer: update on epidemiology and risk factorsJ Cancer Epidemiol2013201396521223737785
   PubMedGoogle Scholar
• BritoJPDaviesLIs there really an increased incidence of thyroid cancer?Curr Opin Endocrinol Diabetes Obes201421540540825102407
   PubMed Web of Science ®Google Scholar
• EnewoldLZhuKRonERising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005Cancer Epidemiol Biomarkers Prev200918378479119240234
   PubMed Web of Science ®Google Scholar
• MorrisLGMyssiorekDImproved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysisAm J Surg2010200445446120561605
   PubMed Web of Science ®Google Scholar
• EliseiRPincheraAAdvances in the follow-up of differentiated or medullary thyroid cancerNat Rev Endocrinol20128846647522473335
   PubMedGoogle Scholar
• FaginJAWellsSJBiologic and clinical perspectives on thyroid cancerN Engl J Med2016375111054106727626519
   PubMed Web of Science ®Google Scholar
• KebebewEItuartePHSipersteinAEDuhQYClarkOHMedullary thyroid carcinoma clinical characteristics, treatment, prognostic factors, and a comparison of staging systemsCancer20008851139114810699905
   PubMedGoogle Scholar
• GillilandFDHuntWCMorrisDMKeyCRPrognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973–1991Cancer19977935645739028369
   PubMed Web of Science ®Google Scholar
• RaueFKotzerkeJReinweinDPrognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary thyroid carcinoma registerClin Investig1993711712
   PubMedGoogle Scholar
• RoosLvan DongenJBellCGIntegrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairsClin Epigenetics20168726798410
   PubMedGoogle Scholar
• KartalKOnderSKosemehmetogluKKilickapSTezelYGKaynarogluVMethylation status of TSHr in well-differentiated thyroid cancer by using cytologic materialBMC Cancer20151582426519197
   PubMedGoogle Scholar
• EllisRJWangYStevensonHSGenome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotypeJ Clin Endocrinol Metab2014992E329E33724423287
   PubMedGoogle Scholar
• AllenNPDonningerHVosMDRASSF6 is a novel member of the RASSF family of tumor suppressorsOncogene200726426203621117404571
   PubMed Web of Science ®Google Scholar
• HessonLBCooperWNLatifFThe role of RASSF1A methylation in cancerDis Markers2007231–2738717325427
   PubMedGoogle Scholar
• GuoCTommasiSLiuLYeeJKDammannRPfeiferGPRASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor networkCurr Biol200717870070517379520
   PubMedGoogle Scholar
• van der WeydenLAdamsDJThe Ras-association domain family (RASSF) members and their role in human tumourigenesisBiochim Biophys Acta200717761588517692468
   PubMed Web of Science ®Google Scholar
• YuGSLaiCYXuYBuCFSuZXAberrant methylation of RASSF1A gene contribute to the risk of renal cell carcinoma: a meta-analysisAsian Pac J Cancer Prev201516114665466926107221
   PubMedGoogle Scholar
• HuangYZWuWWuKXuXNTangWRAssociation of RASSF1A promoter methylation with lung cancer risk: a meta-analysisAsian Pac J Cancer Prev20141523103251032825556469
   PubMedGoogle Scholar
• JiangDShenYDaiDMeta-analyses of methylation markers for prostate cancerTumour Biol20143510104491045525053593
   PubMedGoogle Scholar
• SiJGSuYYHanYHChenRHRole of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysisGenet Test Mol Biomarkers201418639440224665911
   PubMedGoogle Scholar
• AshktorabHRahiHWansleyDToward a comprehensive and systematic methylome signature in colorectal cancersEpigenetics20138880781523975090
   PubMed Web of Science ®Google Scholar
• LiYSXieQYangDYZhengYRole of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studiesMol Biol Rep20144163925393324566681
   PubMedGoogle Scholar
• ShiDTHanMGaoNTianWChenWAssociation of RASSF1A promoter methylation with gastric cancer risk: a meta-analysisTumour Biol201435294394823982879
   PubMedGoogle Scholar
• JiangYCuiLChenWDShenSHDingLDThe prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published dataPLoS One201275e3678022615811
   PubMedGoogle Scholar
• WoolfBOn estimating the relation between blood group and diseaseAnn Hum Genet195519425125314388528
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med200221111539155812111919
   PubMed Web of Science ®Google Scholar
• MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst195922471974813655060
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• SantoroAPannoneGCarosiMABRAF mutation and RASSF1A expression in thyroid carcinoma of southern ItalyJ Cell Biochem201311451174118223192464
   PubMedGoogle Scholar
• BraitMLoyoMRosenbaumECorrelation between BRAF mutation and promoter methylation of TIMP3, RARbeta2 and RASSF1A in thyroid cancerEpigenetics20127771071922694820
   PubMed Web of Science ®Google Scholar
• Mohammadi-aslJLarijaniBKhorgamiZQualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARbeta2 genes in papillary thyroid carcinomaMed Oncol20112841123112820535589
   PubMedGoogle Scholar
• LeeJJGeliJLarssonCGene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancerInt J Oncol200833486186918813801
   PubMed Web of Science ®Google Scholar
• NakamuraNCarneyJAJinLRASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumorsLab Invest20058591065107515980887
   PubMedGoogle Scholar
• XingMCohenYMamboEEarly occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesisCancer Res20046451664166814996725
   PubMedGoogle Scholar
• SchagdarsurenginUGimmOHoang-VuCDralleHPfeiferGPDammannRFrequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinomaCancer Res200262133698370112097277
   PubMed Web of Science ®Google Scholar
• QuFXueWJRASSF1A methylation and its clinical roles in papillary thyroid carcinomaJ Nantong University (Medical Sciences)201232490491
   Google Scholar
• DaiYLCaiDHChenHZhangZZhangHLiJThe association of the methylation of TSHR and RASSF1A with thyroid cancerShaanxi Med J2011401114461449
   Google Scholar
• WangXHZhangGCLiuYLSunGFNongWXYaoESThe detection of RASSF1A promoter methylation in thyroid tumor patientsShaanxi Med J200938790792
   Google Scholar
• KhooMLBeasleyNJEzzatSFreemanJLAsaSLOverexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinomaJ Clin Endocrinol Metab20028741814181811932323
   PubMed Web of Science ®Google Scholar
• EliseiRShioharaMKoefflerHPFaginJAGenetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomasCancer19988310218521939827724
   PubMed Web of Science ®Google Scholar
• KhaledHAl LahloubiNRashadNA review on thyroid cancer during pregnancy: multitasking is requiredJ Adv Res20167456557027408758
   PubMedGoogle Scholar
• StBRZhengLLiuWWinerDAsaSLEzzatSFibroblast growth factor receptors as molecular targets in thyroid carcinomaEndocrinology200514631145115315564323
   PubMedGoogle Scholar
• KondoTZhengLLiuWKurebayashiJAsaSLEzzatSEpigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progressionCancer Res200767115461547017545628
   PubMed Web of Science ®Google Scholar
• JiangJLTianGLChenSJXuLIWangHQPromoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: a meta-analysisExp Ther Med20151041549155526622524
   PubMedGoogle Scholar